N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide

C94H103F2N33O12 — CID 157102187

About N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide

N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide (PubChem CID 157102187) has the molecular formula C94H103F2N33O12 and a molecular weight of 1925.07 g/mol. Its IUPAC name is N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide.

Molecular Properties

• Compound Name: N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide
• PubChem CID: 157102187
• Molecular Formula: C94H103F2N33O12
• Molecular Weight: 1925.07 g/mol
• Exact Mass: 1923.84
• IUPAC Name: N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide
• SMILES: CCOC1CCC(n2cc(NC(=O)c3coc(-c4cn[nH]c4)n3)c(-c3cnccn3)n2)CC1.CCOC1CCC(n2cc(NC(=O)c3coc(-c4cn[nH]c4)n3)c(-c3ncccn3)n2)CC1.O=C(Nc1cn(C2CCC(N3CCOCC3)CC2)nc1-c1cccc(C(F)F)n1)c1coc(-c2cn[nH]c2)n1.O=C(Nc1cn(C2CCC(N3CCOCC3)CC2)nc1-c1ncccn1)c1coc(-c2cn[nH]c2)n1
• InChI: InChI=1S/C26H28F2N8O3.C24H27N9O3.2C22H24N8O3/c27-24(28)20-3-1-2-19(31-20)23-21(32-25(37)22-15-39-26(33-22)16-12-29-30-13-16)14-36(34-23)18-6-4-17(5-7-18)35-8-10-38-11-9-35;34-23(20-15-36-24(30-20)16-12-27-28-13-16)29-19-14-33(31-21(19)22-25-6-1-7-26-22)18-4-2-17(3-5-18)32-8-10-35-11-9-32;1-2-32-16-6-4-15(5-7-16)30-12-17(19(29-30)20-23-8-3-9-24-20)27-21(31)18-13-33-22(28-18)14-10-25-26-11-14;1-2-32-16-5-3-15(4-6-16)30-12-18(20(29-30)17-11-23-7-8-24-17)27-21(31)19-13-33-22(28-19)14-9-25-26-10-14/h1-3,12-15,17-18,24H,4-11H2,(H,29,30)(H,32,37);1,6-7,12-15,17-18H,2-5,8-11H2,(H,27,28)(H,29,34);3,8-13,15-16H,2,4-7H2,1H3,(H,25,26)(H,27,31);7-13,15-16H,2-6H2,1H3,(H,25,26)(H,27,31)
• InChIKey: AFWUXJOMGUWHSB-UHFFFAOYSA-N
• XLogP: 14.10
• TPSA: 540.15 Ų
• H-Bond Donors: 8
• H-Bond Acceptors: 37
• Rotatable Bonds: 27
• Heavy Atoms: 141
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	1925.07
LogP ≤ 5	14.10
H-Bond Donors ≤ 5	8
H-Bond Acceptors ≤ 10	37

Frequently Asked Questions

What is the IUPAC name of N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide?

The IUPAC name of N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide (CID 157102187) is N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide.

What is the SMILES notation for N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide?

The canonical SMILES for N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide is CCOC1CCC(n2cc(NC(=O)c3coc(-c4cn[nH]c4)n3)c(-c3cnccn3)n2)CC1.CCOC1CCC(n2cc(NC(=O)c3coc(-c4cn[nH]c4)n3)c(-c3ncccn3)n2)CC1.O=C(Nc1cn(C2CCC(N3CCOCC3)CC2)nc1-c1cccc(C(F)F)n1)c1coc(-c2cn[nH]c2)n1.O=C(Nc1cn(C2CCC(N3CCOCC3)CC2)nc1-c1ncccn1)c1coc(-c2cn[nH]c2)n1.

What is the InChIKey of N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide?

The InChIKey is AFWUXJOMGUWHSB-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H28F2N8O3.C24H27N9O3.2C22H24N8O3/c27-24(28)20-3-1-2-19(31-20)23-21(32-25(37)22-15-39-26(33-22)16-12-29-30-13-16)14-36(34-23)18-6-4-17(5-7-18)35-8-10-38-11-9-35;34-23(20-15-36-24(30-20)16-12-27-28-13-16)29-19-14-33(31-21(19)22-25-6-1-7-26-22)18-4-2-17(3-5-18)32-8-10-35-11-9-32;1-2-32-16-6-4-15(5-7-16)30-12-17(19(29-30)20-23-8-3-9-24-20)27-21(31)18-13-33-22(28-18)14-10-25-26-11-14;1-2-32-16-5-3-15(4-6-16)30-12-18(20(29-30)17-11-23-7-8-24-17)27-21(31)19-13-33-22(28-19)14-9-25-26-10-14/h1-3,12-15,17-18,24H,4-11H2,(H,29,30)(H,32,37);1,6-7,12-15,17-18H,2-5,8-11H2,(H,27,28)(H,29,34);3,8-13,15-16H,2,4-7H2,1H3,(H,25,26)(H,27,31);7-13,15-16H,2-6H2,1H3,(H,25,26)(H,27,31).

What are the key properties of N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide?

N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide has a molecular weight of 1925.07 g/mol, XLogP of 14.10, 27 rotatable bonds, 8 hydrogen bond donors, and 37 hydrogen bond acceptors.

Where does this data come from?

All data for N-[3-[6-(difluoromethyl)-2-pyridinyl]-1-(4-morpholin-4-ylcyclohexyl)pyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrazin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-ethoxycyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide;N-[1-(4-morpholin-4-ylcyclohexyl)-3-pyrimidin-2-ylpyrazol-4-yl]-2-(1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide is sourced from PubChem (CID 157102187), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).